Numinus’s Acquisition of Novamind May Signal More Consolidation to Come
Survey Finds Those Who Take Psilocybin Less Likely to Abuse Opioids
Psychedelics Meets the Theory of Everything 
A New Database Seeks to Prevent “Bad” Psychedelic Patents
Decrim Movement Split Over Peyote, Possession Limits, and Tactics
Hyphae Labs Expands Harm Reduction to Consider Psilocybin 
Pioneering Clergy of Diverse Religions Embrace Psychedelics
So You Wish To See?
Decriminalize Nature Feels Growing Pains as Local Groups Clash with Board
Protestors Target the DEA in Support of Psilocybin for Terminally Ill Patients
Researchers May Have Created LSD-Analogs that Treat Depression Without the Trip
Survey Suggests Psychedelics are Linked to Neo-Shamanistic Beliefs
Funders at Johns Hopkins Shape The Future of Psychedelic Research
These Natural Psilocybin Droplets Come in Exact Dosages and Don’t Upset Your Stomach
Terminally Ill Patients Fight for Access to Psilocybin Under Federal “Right to Try” Act